webinar: a pharmacogenetic (pgx) blindspot: the prevalence and impact of cyp2d6 hybrid alleles
Published 3 years ago • 719 plays • Length 1:09:40Download video MP4
Download video MP3
Similar videos
-
1:03:14
amp 2019 pgx workshop: the prevalence and impact of cyp2d6 hybrid alleles
-
42:52
webinar: role of pharmacogenetic testing in personalized medicine
-
51:59
webinar: unlocking precision medicine - implementing a novel pgx prescribing program
-
51:51
gyn oncology virtual symposium series | targeting dna repair and immunotherapy
-
55:28
visions 2013 - gene therapy clinical trial updates
-
4:44
dr. naomi chadderton: new promising gene therapy for the treatment of multiple eye diseases
-
20:37
visions 2022 science preview with claire gelfman, phd
-
1:40
glaucoma genes and new opportunities for therapy
-
8:06
gene expression & gene delivery interview with regenxbio's steve pakola, md at ois@asrs 2019
-
53:01
webinar: liquid biopsy - applications of ctcs and ctdna as a non-invasive tumor tracker
-
14:08
david pauza speaks at 2017 cell gene meeting on the mesa pt.1/2
-
6:20
what's new in glaucoma medication and diagnostics
-
1:40:01
genomind professional pgx express™ launch– dr. stahl & genomind leaders, apa conference (2019)
-
5:12
cyagen and neurophth enter ai-aav collaboration for ophthalmic gene therapy
-
2:26
dr. jeff chulay on gene therapy
-
19:04
the expanding dna and gene therapy market
-
0:55
intro to my channel
-
1:28
implementing automation technology in the cgt space
-
2:53
multi-partner grant for clinical trials for rare eye disease
-
1:37
nine network - flinders researchers discover new glaucoma-related genes
-
9:50
metabesity 2019: artificial intelligence in preclinical discovery and clinical development